{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:56:41Z","timestamp":1781614601053,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Pulmonary metastasis is relatively rare among esophageal cancer patients, and there is a limited body of research in this regard. This study used clinical and pathological indicators from monitoring, epidemiological, and Surveillance, Epidemiology, and End Results (SEER) databases to look at the risk factors for patients who develop pulmonary metastasis. This study aims to explore the risk factors for lung metastasis in esophageal cancer patients and their impact on prognosis, and to construct a nomogram model for predicting the survival period of patients with lung metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We obtained data on esophageal cancer patients from the Surveillance, SEER database between 2010 and 2015. Patients with esophageal cancer lung metastasis were divided into a training group and a testing group. Univariate and multivariate analyses were performed on the training set to identify independent risk factors for esophageal cancer lung metastasis, and a nomogram model was constructed to predict overall survival (OS). The model\u2019s discriminatory ability and calibration were evaluated using the C-index, area under the receiver operating characteristic (ROC) curve (AUC), and calibration curve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 10,035 esophageal cancer patients were included in this study, with 590 diagnosed with lung metastasis. Single-factor and multi-factor logistic regression analyses revealed several risk factors associated with esophageal cancer lung metastasis, including male gender, higher tumor grades (Grade II and Grade III), advanced T stage, and the presence of bone, brain, and liver metastases. Patients diagnosed with esophageal cancer who have pulmonary metastases have a median overall survival of six months. For patients with esophageal cancer with lung metastasis, significant prognostic factors identified by Cox regression analysis included tumor grade (grade II and III), T2 lymph node metastasis, T3 lymph node metastasis, and the presence of bone metastasis. The constructed nomogram was validated by ROC analysis and calibration curves, demonstrating good predictive accuracy and discriminatory power.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There are certain differences in risk and prognostic factors between patients with esophageal cancer and lung metastasis. ROC curves and calibration curves validated that the dynamic nomogram has certain predictive performance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-025-04025-4","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T12:51:57Z","timestamp":1760446317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a prognostic prediction model for patients with lung metastasis of esophageal cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Xianzhe","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"4025_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejca.2020.08.002","volume":"138","author":"S Liu","year":"2020","unstructured":"Liu S, Wen J, Yang H, et al. Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010. Eur J Cancer. 2020;138:113\u201321. https:\/\/doi.org\/10.1016\/j.ejca.2020.08.002.","journal-title":"Eur J Cancer"},{"issue":"3","key":"4025_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4025_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4025_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","volume":"64","author":"M Arnold","year":"2015","unstructured":"Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381\u20137. https:\/\/doi.org\/10.1136\/gutjnl-2014-308124.","journal-title":"Gut"},{"issue":"2","key":"4025_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/j.gastro.2015.04.053","volume":"149","author":"JH Rubenstein","year":"2015","unstructured":"Rubenstein JH, Shaheen NJ. Epidemiology, diagnosis, and management of esophageal adenocarcinoma. Gastroenterology. 2015;149(2):302\u2013e3171. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.053.","journal-title":"Gastroenterology"},{"issue":"2","key":"4025_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2017.07.046","volume":"154","author":"HG Coleman","year":"2018","unstructured":"Coleman HG, Xie SH, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018;154(2):390\u2013405. https:\/\/doi.org\/10.1053\/j.gastro.2017.07.046.","journal-title":"Gastroenterology"},{"issue":"9","key":"4025_CR7","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.21037\/jtd.2017.08.72","volume":"9","author":"D Ai","year":"2017","unstructured":"Ai D, Zhu H, Ren W, et al. Patterns of distant organ metastases in esoph-ageal cancer: a population-based study. J Thorac Dis. 2017;9(9):3023\u201330. https:\/\/doi.org\/10.21037\/jtd.2017.08.72.","journal-title":"J Thorac Dis"},{"issue":"21","key":"4025_CR8","doi-asserted-by":"publisher","first-page":"31137","DOI":"10.18632\/oncotarget.9082","volume":"7","author":"T Sasahira","year":"2016","unstructured":"Sasahira T, Kirita T, Nishiguchi Y, et al. A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma. Oncotarget. 2016;7(21):31137\u201352. https:\/\/doi.org\/10.18632\/oncotarget.9082.","journal-title":"Oncotarget"},{"key":"4025_CR9","doi-asserted-by":"publisher","first-page":"1051841","DOI":"10.3389\/fimmu.2022.1051841","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Liu T, Ding Z. Neoadjuvant immunotherapy for resectable esophage-al cancer: A review. Front Immunol. 2022;13:1051841. https:\/\/doi.org\/10.3389\/fimmu.2022.1051841.","journal-title":"Front Immunol"},{"issue":"11","key":"4025_CR10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jcma.2014.05.014","volume":"77","author":"MQ Chen","year":"2014","unstructured":"Chen MQ, Xu BH, Zhang YY. Analysis of prognostic factors for esophageal squamous cell carcinoma with distant organ metastasis at initial diagnosis. J Chin Med Association. 2014;77(11):562\u20136. https:\/\/doi.org\/10.1016\/j.jcma.2014.05.014.","journal-title":"J Chin Med Association"},{"issue":"S22","key":"4025_CR11","doi-asserted-by":"publisher","first-page":"S2671","DOI":"10.21037\/jtd.2018.03.182","volume":"10","author":"XB D\u2019Journo","year":"2018","unstructured":"D\u2019Journo XB. Clinical implication of the innovations of the 8th edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis. 2018;10(S22):S2671\u201381. https:\/\/doi.org\/10.21037\/jtd.2018.03.182.","journal-title":"J Thorac Dis"},{"issue":"7","key":"4025_CR12","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/cncr.11228","volume":"97","author":"C Mariette","year":"2003","unstructured":"Mariette C, Balon J, Piessen G, Fabre S, Van Seuningen I, Triboulet J. Pattern of recurrence following complete resection of esophageal carcinoma a-nd factors predictive of recurrent disease. Cancer. 2003;97(7):1616\u201323. https:\/\/doi.org\/10.1002\/cncr.11228.","journal-title":"Cancer"},{"key":"4025_CR13","doi-asserted-by":"publisher","first-page":"155969","DOI":"10.1016\/j.phymed.2024.155969","volume":"135","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Kang N, Zhang L, et al. Targeting and degradation of OTUB1 by Erianin for antimetastasis in esophageal squamous cell carcinoma. Phytomedicine. 2024;135:155969. https:\/\/doi.org\/10.1016\/j.phymed.2024.155969.","journal-title":"Phytomedicine"},{"issue":"30","key":"4025_CR14","doi-asserted-by":"publisher","first-page":"2401590","DOI":"10.1002\/advs.202401590","volume":"11","author":"CN Wong","year":"2024","unstructured":"Wong CN, Zhang Y, Ru B, et al. Identification and characterization of metastasis-Initiating cells in ESCC in a Multi-Timepoint pulmonary metastasis mouse model. Adv Sci. 2024;11(30):2401590. https:\/\/doi.org\/10.1002\/advs.202401590.","journal-title":"Adv Sci"},{"key":"4025_CR15","doi-asserted-by":"publisher","unstructured":"Guo X, Chen C, Zhao J, et al. Neoadjuvant chemoradiotherapy vs chemoimmunotherapy for esophageal squamous cell carcinoma. JAMA Surg. 2025; 160(5):565-574 https:\/\/doi.org\/10.1001\/jamasurg.2025.0220","DOI":"10.1001\/jamasurg.2025.0220"},{"issue":"12","key":"4025_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2152\/jmi.68.129","volume":"68","author":"M Sohda","year":"2021","unstructured":"Sohda M, Yoshida T, Nakazawa N, et al. Comparative study on recurrence pattern and treatment method after radical esophagectomy for esophageal cancer. J Med Invest. 2021;68(12):129\u201335. https:\/\/doi.org\/10.2152\/jmi.68.129.","journal-title":"J Med Invest"},{"issue":"2","key":"4025_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00268-012-1830-7","volume":"37","author":"H Ichida","year":"2013","unstructured":"Ichida H, Imamura H, Yoshimoto J, et al. Pattern of postoperative Recurre-nce and hepatic and\/or pulmonary resection for liver and\/or lung Metas-tases from esophageal carcinoma. World J Surg. 2013;37(2):398\u2013407. https:\/\/doi.org\/10.1007\/s00268-012-1830-7.","journal-title":"World J Surg"},{"issue":"1","key":"4025_CR18","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","volume":"3","author":"EC Smyth","year":"2017","unstructured":"Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal cancer. Nat Rev Dis Primers. 2017;3(1):17048. https:\/\/doi.org\/10.1038\/nrdp.2017.48.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4025_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/cells12010114","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang Y, Peng L, Zhang L. Research progress on the predicting factors and coping strategies for postoperative recurrence of esophageal cancer. Cells. 2022;12(1):114. https:\/\/doi.org\/10.3390\/cells12010114.","journal-title":"Cells"},{"key":"4025_CR20","doi-asserted-by":"publisher","unstructured":"Ichida H, Imamura H, Yoshimoto J, Sugo H, Kajiyama Y, Tsurumaru M, Suzuki K, Ishizaki Y, Kawasaki S. Pattern of postoperative recurrence and hepatic and\/or pulmonary resection for liver and\/or lung metastases from esophageal carcinoma. World J Surg. 2013;37(2):398\u2013407. https:\/\/doi.org\/10.1007\/s00268-012-1830-7. PMID: 23142988.","DOI":"10.1007\/s00268-012-1830-7"},{"issue":"9","key":"4025_CR21","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.21037\/jtd.2017.08.72","volume":"9","author":"D Ai","year":"2017","unstructured":"Ai D, Zhu H, Ren W, Chen Y, Liu Q, Deng J, Ye J, Fan J, Zhao K. Patterns of distant organ metastases in esophageal cancer: a population-based study. J Thorac Dis. 2017;9(9):3023\u201330. PMID: 29221275; PMCID: PMC5708381.","journal-title":"J Thorac Dis"},{"key":"4025_CR22","doi-asserted-by":"publisher","first-page":"603953","DOI":"10.3389\/fonc.2021.603953","volume":"11","author":"J Guo","year":"2021","unstructured":"Guo J, Zhang S, Li H, Hassan MOO, Lu T, Zhao J, et al. Lung metastases in newly diagnosed esophageal cancer: A Population-Based study. Front Oncol. 2021;11:603953. https:\/\/doi.org\/10.3389\/fonc.2021.603953.","journal-title":"Front Oncol"},{"key":"4025_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1245\/s10434-018-6929-0","volume":"26","author":"X Tang","year":"2019","unstructured":"Tang X, Zhou X, Li Y, Tian X, Wang Y, Huang M, et al. A novel nomogram and risk classification system predicting the Cancer-Specific survival of patients with initially diagnosed metastatic esophageal cancer: A SEER-Based study. Ann Surg Oncol. 2019;26:321\u20138. https:\/\/doi.org\/10.1245\/s10434-018-6929-0.","journal-title":"Ann Surg Oncol"},{"key":"4025_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1186\/s12885-021-08802-8","volume":"21","author":"S Cheng","year":"2021","unstructured":"Cheng S, Yang L, Dai X, Wang J, Han X. The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database. BMC Cancer. 2021;21:1057. https:\/\/doi.org\/10.1186\/s12885-021-08802-8.","journal-title":"BMC Cancer"},{"issue":"1","key":"4025_CR25","doi-asserted-by":"publisher","first-page":"28280","DOI":"10.1038\/srep28280","volume":"6","author":"SG Wu","year":"2016","unstructured":"Wu SG, Xie WH, Zhang ZQ, et al. Surgery combined with radiotherapy improved survival in metastatic esophageal cancer in a surveillance epidemiology and end results Population-based study. Sci Rep. 2016;6(1):28280. https:\/\/doi.org\/10.1038\/srep28280.","journal-title":"Sci Rep"},{"issue":"8","key":"4025_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1442-2050.2010.01069.x","volume":"23","author":"T Tanaka","year":"2010","unstructured":"Tanaka T, Fujita H, Matono S, et al. Outcomes of multimodality therapy for stage IVB esophageal cancer with distant organ metastasis (M1-Org): esophageal cancer with organ metastasis. Dis Esophagus. 2010;23(8):646\u201351. https:\/\/doi.org\/10.1111\/j.1442-2050.2010.01069.x.","journal-title":"Dis Esophagus"},{"key":"4025_CR27","doi-asserted-by":"publisher","first-page":"1457612","DOI":"10.3389\/fimmu.2024.1457612","volume":"15","author":"N Wu","year":"2024","unstructured":"Wu N, Cai J, Jiang J, et al. Biomarkers of lymph node metastasis in esophageal cancer. Front Immunol. 2024;15:1457612. https:\/\/doi.org\/10.3389\/fimmu.2024.1457612.","journal-title":"Front Immunol"},{"issue":"6","key":"4025_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/JTO.0b013e31828b5172","volume":"8","author":"PM Forde","year":"2013","unstructured":"Forde PM, Kelly RJ. Chemotherapeutic and targeted strategies for locally advanced and metastatic esophageal cancer. J Thorac Oncol. 2013;8(6):673\u201384. https:\/\/doi.org\/10.1097\/JTO.0b013e31828b5172.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"4025_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12029-021-00610-4","volume":"53","author":"HF Ghazy","year":"2022","unstructured":"Ghazy HF, El-Hadaad HA, Wahba HA, Abbas R, Abbas OA. Metastatic esophageal carcinoma: prognostic factors and survival. J Gastrointest Canc. 2022;53(2):446\u201350. https:\/\/doi.org\/10.1007\/s12029-021-00610-4.","journal-title":"J Gastrointest Canc"},{"issue":"8","key":"4025_CR30","doi-asserted-by":"publisher","first-page":"101127","DOI":"10.1016\/j.tranon.2021.101127","volume":"14","author":"J Yu","year":"2021","unstructured":"Yu J, Hu W, Yao N, Sun M, Li X, Wang L, Yang Y, Li B. Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis. Transl Oncol. 2021;14(8):101127. https:\/\/doi.org\/10.1016\/j.tranon.2021.101127.","journal-title":"Transl Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04025-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04025-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04025-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:13:08Z","timestamp":1781611988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04025-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4025"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04025-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SEER database is freely available for download by researchers, with private patient information removed. Therefore, no additional ethics statement from the author\u2019s institution is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"369"}}